Please login to the form below

Not currently logged in
Email:
Password:

Mysimba

This page shows the latest Mysimba news and features for those working in and with pharma, biotech and healthcare.

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study

None of these has made significant headway since their US launches, and of the three only Orexigen's drug (branded as  Mysimba) has been backed in Europe, with both Belviq and

Latest news

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    s drug under the Mysimba brand name last December.  . ... The latest development means European doctors could have three drugs at their disposal to manage obesity patients in the coming months, with Saxenda and Mysimba slotting into the market alongside

  • Orexigen’s obesity pill Mysimba set for European approval Orexigen’s obesity pill Mysimba set for European approval

    The CHMP has recommended a marketing authorisation for Mysimba (naltrexone/bupropion) for weight management of overweight or obese adults. ... Across these studies, more patients treated with Mysimba achieved clinically-relevant weight loss than patients

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics